Updated:
Stassets Investment
Stassets Investment focuses on the healthcare sector, specializing in early-stage investments in pharmaceuticals, diagnostics/medical devices, digital...
Stassets Investment
Stassets Investment focuses on the healthcare sector, specializing in early-stage investments in pharmaceuticals, diagnostics/medical devices, digital healthcare, cosmeceuticals, and nutraceuticals. The firm has made 19 investments, including a PIPE investment in Orum Therapeutics on December 18, 2025. Stassets Investment has 2 portfolio exits, with Orum Therapeutics being one of them, exiting on February 14, 2025.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Frequently asked questions
What investment stages does Stassets Investment target?
Stassets Investment deploys capital across multiple venture stages, including early-stage seed rounds, start-up financing, and expansion or late-stage growth equity. This indicates a full-lifecycle venture approach rather than a narrow stage-specific mandate. Specific fund structures and individual stage allocations are not publicly disclosed.
Who runs investment decisions at Stassets Investment?
The firm's key decision-makers and investment committee composition are not publicly disclosed. Available records do not name any managing partners, principals, or senior investment professionals. This level of personnel opacity is consistent with smaller Korean asset managers that do not engage in international fundraising or media outreach.
How does Stassets Investment source proprietary deal flow?
Given the firm's exclusively domestic South Korean focus and minimal public profile, deal flow likely originates through local founder networks, domestic venture communities, and relationship-driven introductions rather than international co-investor syndicates or inbound pitch processes. The firm does not maintain a LinkedIn presence or publish thought leadership content that would indicate a broad inbound sourcing pipeline.
Is Stassets Investment structured as a family office or an institutional fund manager?
Stassets Investment is categorized as an asset manager with a private equity and venture capital strategy, but its exact capital base is not publicly documented. The lack of disclosed limited partners or institutional backers leaves open the possibility that it manages proprietary or family-originated capital alongside any external commitments.
Does Stassets Investment participate in fund commitments or only direct deals?
Public records describe only direct investment stages — seed, start-up, and growth — without reference to fund-of-funds commitments or allocations to other general partners. This suggests a direct-deal model, though the firm's full mandate may also include undisclosed LP commitments to other Korean venture funds.
Which sectors does Stassets Investment focus on?
The firm's public materials do not specify sector preferences, instead describing a generalist venture mandate across early-stage and growth-stage companies. Given its Seoul headquarters, likely exposure includes South Korea's dominant technology sectors such as semiconductors, consumer internet, biotechnology, and enterprise software, though no named portfolio companies confirm this.
What is Stassets Investment's known track record or notable exits?
No portfolio companies, realized exits, or fund-performance metrics are available in public records. The firm does not disclose its investment history, fund vintages, or returns data, making it difficult for external allocators to assess realized track record without direct relationships with the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: